Role adjuvant therapy colorectal cancer decades disappointing adjuvant therapy trials resectable colorectal cancer results basis cautious optimism Adjuvant fluorouracil-containing regimens modest treatment benefit colonic adenocarcinomas promising chemotherapy approaches present appear fluorouracil-levamisole fluorouracil-leucovorin regimens optimal schedule dose agents Portal vein chemotherapy infusion studies promising inconclusive results date data large group studies available role modality rectal cancer adjuvant radiotherapy modest consistent ability local recurrence survival advantage optimal dose sequencing radiotherapy cooperative group studies optimal use radiotherapy combination chemotherapy independent role chemotherapy rectal cancer unclear suggestive evidence adjuvant chemotherapy effective rectal cancer primaries proximal peritoneal reflection large number unresolved questions following interim treatment recommendations Patients Dukes rectal colonic adenocarcinomas appropriate adjuvant clinical trial feasible setting protocol sound rationale Dukes rectal cancer combination chemotherapy postoperative radiotherapy chemotherapy fluorouracil leucovorin proximal colonic tumors pelvic peritoneal reflection improvements survival patients Dukes disease adjuvant therapy group clinical study Patients Dukes tumors fluorouracil-levamisole 